A small-molecule ICMT inhibitor delays senescence of Hutchinson-Gilford progeria syndrome cells
Xue Chen(Karolinska Institutet), Martin O. Bergö(Karolinska Institutet), Maria Eriksson(Karolinska Institutet), Haidong Yao(Northeast Agricultural University), Mohamed X. Ibrahim(Sahlgrenska University Hospital), Gwladys Revêchon(Karolinska Institutet), Ian M. Ahearn(VA NY Harbor Healthcare System), Mark R. Philips(New York University), Clotilde Wiel(Université Claude Bernard Lyon 1), Elin Tüksammel(Karolinska Institutet), Ting Wang(Jilin University), Muhammad Kashif(Karolinska Institutet), Staffan Strömblad(Karolinska Institutet), Yiran Liu(China People's Public Security University), Jianjiang Hu(Karolinska Institutet)
Cited by 27
Related Papers
Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome
|Nature|2003|2.2k
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
|Journal of Clinical Investigation|1995|832
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
|Cell Metabolism|2018|420
Integrin αvβ3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during Angiogenesis
|The Journal of Cell Biology|1998|395
Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway
|Acta Pharmacologica Sinica|2016|182